These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17393579)

  • 21. Many roads from mTOR to eIF4F.
    Thoreen CC
    Biochem Soc Trans; 2013 Aug; 41(4):913-6. PubMed ID: 23863155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of cap-dependent translation initiation in the early stage porcine parthenotes.
    Susor A; Jelínková L; Karabínová P; Torner H; Tomek W; Kovárová H; Kubelka M
    Mol Reprod Dev; 2008 Dec; 75(12):1716-25. PubMed ID: 18386287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor-1 (IGF-1) and leucine activate pig myogenic satellite cells through mammalian target of rapamycin (mTOR) pathway.
    Han B; Tong J; Zhu MJ; Ma C; Du M
    Mol Reprod Dev; 2008 May; 75(5):810-7. PubMed ID: 18033679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide mediates NMDA-induced persistent inhibition of protein synthesis through dephosphorylation of eukaryotic initiation factor 4E-binding protein 1 and eukaryotic initiation factor 4G proteolysis.
    Petegnief V; Font-Nieves M; Martín ME; Salinas M; Planas AM
    Biochem J; 2008 May; 411(3):667-77. PubMed ID: 18215131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic alcohol feeding impairs mTOR(Ser 2448) phosphorylation in rat hearts.
    Vary TC; Deiter G; Lantry R
    Alcohol Clin Exp Res; 2008 Jan; 32(1):43-51. PubMed ID: 18028531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.
    Ronellenfitsch MW; Brucker DP; Burger MC; Wolking S; Tritschler F; Rieger J; Wick W; Weller M; Steinbach JP
    Brain; 2009 Jun; 132(Pt 6):1509-22. PubMed ID: 19416948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deregulation of cell growth and malignant transformation.
    Sulić S; Panić L; Dikić I; Volarević S
    Croat Med J; 2005 Aug; 46(4):622-38. PubMed ID: 16100767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptotic effect of melatonin on ER-positive breast cancer cell lines: ADGRL4 gene expression and promoter methylation.
    Rajabi A; Safaralizadeh R; Saber A; Pourmahdi M; Teimourian S; Montazeri V; Fakhrjou A; Hosseinpourfeizi M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; ():. PubMed ID: 39177783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical
    Weidle UH; Nopora A
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):349-368. PubMed ID: 33994361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.
    Liang S; Desai AA; Black SM; Tang H
    Adv Exp Med Biol; 2021; 1303():275-303. PubMed ID: 33788198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long non-coding RNA AK023948 enhances tumor progression in hepatocellular carcinoma.
    Ye B; Hu B; Zheng Z; Zheng R; Shi Y
    Exp Ther Med; 2017 Oct; 14(4):3658-3664. PubMed ID: 29042961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of mTOR/70S6K signaling pathway in pathological scar fibroblasts and the effects of resveratrol intervention.
    Tang ZM; Zhai XX; Ding JC
    Mol Med Rep; 2017 May; 15(5):2546-2550. PubMed ID: 28447760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor binding protein-3 mediates interleukin-24-induced apoptosis through inhibition of the mTOR pathway in prostate cancer.
    Du Y; Long Q; Shi Y; Liu X; Li X; Zeng J; Gong Y; Li L; Wang X; He D
    Oncol Rep; 2015 Nov; 34(5):2273-81. PubMed ID: 26323436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients.
    Zuckerman NS; Yu H; Simons DL; Bhattacharya N; Carcamo-Cavazos V; Yan N; Dirbas FM; Johnson DL; Schwartz EJ; Lee PP
    Int J Cancer; 2013 Jun; 132(11):2537-47. PubMed ID: 23136075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-transcriptional regulation in cancer progression : Microenvironmental control of alternative splicing and translation.
    Jewer M; Findlay SD; Postovit LM
    J Cell Commun Signal; 2012 Dec; 6(4):233-48. PubMed ID: 23054595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mTOR is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesis.
    Chou SD; Prince T; Gong J; Calderwood SK
    PLoS One; 2012; 7(6):e39679. PubMed ID: 22768106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of STAT3 gene silencing and rapamycin on apoptosis in hepatocarcinoma cells.
    Zhang Y; Zhang JW; Lv GY; Xie SL; Wang GY
    Int J Med Sci; 2012; 9(3):216-24. PubMed ID: 22408571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of calorie restriction mimetics as therapeutics for obesity, diabetes, inflammatory and neurodegenerative diseases.
    Chiba T; Tsuchiya T; Komatsu T; Mori R; Hayashi H; Shimokawa I
    Curr Genomics; 2010 Dec; 11(8):562-7. PubMed ID: 21629433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the mTOR signaling pathway: from laboratory bench to bedside and back again.
    Abraham RT
    F1000 Biol Rep; 2009 Jan; 1():8. PubMed ID: 20948608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.